OA07645A - Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant. - Google Patents

Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant.

Info

Publication number
OA07645A
OA07645A OA58217A OA58217A OA07645A OA 07645 A OA07645 A OA 07645A OA 58217 A OA58217 A OA 58217A OA 58217 A OA58217 A OA 58217A OA 07645 A OA07645 A OA 07645A
Authority
OA
OAPI
Prior art keywords
intermediates
obtaining
medicaments containing
pyridazine derivatives
psychotropic action
Prior art date
Application number
OA58217A
Other languages
English (en)
French (fr)
Inventor
Kathleen Biziere
Jean-Paul Kan
Camille-George Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8301366A external-priority patent/FR2540115B1/fr
Priority claimed from FR8318433A external-priority patent/FR2555178B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of OA07645A publication Critical patent/OA07645A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA58217A 1983-01-28 1984-01-26 Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant. OA07645A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301366A FR2540115B1 (fr) 1983-01-28 1983-01-28 Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
FR8318433A FR2555178B1 (fr) 1983-11-18 1983-11-18 Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
OA07645A true OA07645A (fr) 1985-05-23

Family

ID=26223263

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58217A OA07645A (fr) 1983-01-28 1984-01-26 Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant.

Country Status (25)

Country Link
US (2) US4565814A (de)
EP (1) EP0116494B1 (de)
KR (1) KR910000639B1 (de)
AU (1) AU566352B2 (de)
CA (1) CA1218655A (de)
CS (1) CS274405B2 (de)
DD (1) DD215542A5 (de)
DE (1) DE3469026D1 (de)
DK (3) DK159969C (de)
ES (1) ES529108A0 (de)
FI (1) FI77453C (de)
GR (1) GR81682B (de)
HU (1) HU192975B (de)
IE (1) IE56750B1 (de)
IL (1) IL70755A (de)
MA (1) MA20019A1 (de)
NO (1) NO840329L (de)
NZ (1) NZ206957A (de)
OA (1) OA07645A (de)
PH (1) PH21476A (de)
PL (1) PL143994B1 (de)
PT (1) PT77994B (de)
SG (1) SG9389G (de)
SU (1) SU1274623A3 (de)
YU (1) YU14184A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
DE3672536D1 (de) * 1985-06-14 1990-08-16 Lilly Co Eli Fungizide pyridazine.
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
NZ509748A (en) * 1998-08-20 2003-01-31 Toyama Chemical Co Ltd Nitrogenous heterocyclic carboxamide derivatives or salts useful as antiviral agents
EP1144388B1 (de) 1999-01-22 2010-01-13 Elan Pharmaceuticals, Inc. Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
CN1984904A (zh) * 2004-05-08 2007-06-20 神经能质公司 3-芳基-5,6-二取代哒嗪
EP1741709A1 (de) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka
JP5081828B2 (ja) 2005-09-29 2012-11-28 エラン ファーマシューティカルズ,インコーポレイテッド Vla−4によって媒介される白血球粘着を阻害するカルバメート化合物
NZ567270A (en) 2005-09-29 2011-06-30 Elan Pharm Inc Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
KR20080100271A (ko) 2006-02-27 2008-11-14 엘란 파마슈티칼스, 인크. Vla-4에 의해 매개되는 백혈구 부착을 억제하는 피리미디닐 술폰아미드 화합물
JP2012525336A (ja) 2009-04-27 2012-10-22 エラン ファーマシューティカルズ,インコーポレイテッド α−4インテグリンのピリジノンアンタゴニスト
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant

Also Published As

Publication number Publication date
NZ206957A (en) 1987-06-30
DK162218C (da) 1992-03-02
NO840329L (no) 1984-07-30
SG9389G (en) 1989-07-07
AU2372884A (en) 1984-08-02
HU192975B (en) 1987-08-28
KR910000639B1 (ko) 1991-01-31
YU14184A (en) 1986-10-31
DK621689D0 (da) 1989-12-08
DK621589D0 (da) 1989-12-08
IL70755A0 (en) 1984-04-30
GR81682B (de) 1984-12-12
US4565814A (en) 1986-01-21
FI77453B (fi) 1988-11-30
DK162218B (da) 1991-09-30
SU1274623A3 (ru) 1986-11-30
DK25984A (da) 1984-07-29
PL143994B1 (en) 1988-04-30
IL70755A (en) 1987-03-31
CA1218655A (en) 1987-03-03
DK621589A (da) 1989-12-08
PT77994A (fr) 1984-02-01
CS274405B2 (en) 1991-04-11
DK159969C (da) 1991-05-27
DK159969B (da) 1991-01-07
DE3469026D1 (en) 1988-03-03
FI840349A (fi) 1984-07-29
FI840349A0 (fi) 1984-01-27
PT77994B (fr) 1986-04-10
DK162219C (da) 1992-03-02
US4631280A (en) 1986-12-23
PH21476A (en) 1987-10-28
EP0116494B1 (de) 1988-01-27
FI77453C (fi) 1989-03-10
IE840148L (en) 1984-07-28
PL245932A1 (en) 1985-05-21
MA20019A1 (fr) 1984-10-01
CS61484A2 (en) 1990-09-12
IE56750B1 (en) 1991-12-04
ES8500253A1 (es) 1984-10-01
DK621689A (da) 1989-12-08
ES529108A0 (es) 1984-10-01
DK162219B (da) 1991-09-30
DD215542A5 (de) 1984-11-14
EP0116494A1 (de) 1984-08-22
DK25984D0 (da) 1984-01-20
AU566352B2 (en) 1987-10-15
KR840007587A (ko) 1984-12-08

Similar Documents

Publication Publication Date Title
OA07645A (fr) Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant.
MA21184A1 (fr) Procede de preparation de l'errantiomere dextrogyre de l'alpha-(tetrahydro-4,5,6,7thiero(3,2-c)pyridyl-5)(chloro-2 phenyl)-acetate de methyle.
OA08643A (fr) Composition détergente, visqueuse, diluable et son procédé d'obtention.
OA07991A (fr) Dérivés de nitrométhylène, produits intermédiaires correspondants, leur procédé de production et insecticides contenant ces dérivés.
OA07644A (fr) Dérivés de la pyridazine amino -substitués en position 3, actifs sur le système nerveux central, procédé d'obtention et médicaments en contenant.
IT8423264A0 (it) Nuovo processo per la preparazione dell'acido 2(4-fluorofenil)alfa-metil-5-benzoxazoloacetico.
FR2699184B1 (fr) Nouveaux dérivés de collagène, leur procédé d'obtention et leur application à la préparation de biomatériaux.
OA09209A (fr) "Dérivés de la thiéno-triazolo-diazépine, un procédé de préparation desdits composés et une composition thérapeutique les contenant".
MA21588A1 (fr) Derives d'ether de n-pheryl pyrazole-4-yle, compositions les contenant et leur procede de preparation.
IT1244006B (it) Procedimento di purificazione dell'ammoniaca.
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
FR2693722B1 (fr) Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
OA08734A (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant.
FR2574429B1 (fr) Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2695125B1 (fr) Nouveaux composés poly-iodés, procédé de préparation, produit de contraste les contenant.
FR2691464B1 (fr) Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments.
ITTO930806A0 (it) Purificazione dell' 1,1-dicloro-1-fluoroetano.
FR2592660B1 (fr) Procede d'obtention de mout.
IT8720019A0 (it) Processo per la sintesi dell'alfa-(1-metiletil)-3,4-dimetossibenzeneacetonitrile.
DE3563436D1 (en) Methyl substituted bicyclo ad2.2.1 bdheptane nitriles, process for production of these nitriles and their use as scents
OA08831A (fr) Dérivés de la 1- (1,1-diphényl)-1alcényl -pipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
FR2540115B1 (fr) Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
OA06933A (fr) Procédé d'obtention d'une fraction de mandassi.
FR2689502B1 (fr) Procédé de production de 1, 1-dichloro-1-fluoréthane ("141b") stabilisé et produit obtenu.
OA08257A (fr) Nouvemmes carboxamidoguanidines, leur procédé d'obtention et les compositions pharmaceutiques en renfermant.